These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28192402)

  • 1. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
    Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
    Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
    Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.
    Feng T; Dzieran J; Gu X; Marhenke S; Vogel A; Machida K; Weiss TS; Ruemmele P; Kollmar O; Hoffmann P; Grässer F; Allgayer H; Fabian J; Weng HL; Teufel A; Maass T; Meyer C; Lehmann U; Zhu C; Mertens PR; Gao CF; Dooley S; Meindl-Beinker NM
    Clin Sci (Lond); 2015 Jun; 128(11):761-74. PubMed ID: 25602745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.
    Li Q; Gao Y; Jia Z; Mishra L; Guo K; Li Z; Le X; Wei D; Huang S; Xie K
    Gastroenterology; 2012 Sep; 143(3):799-810.e2. PubMed ID: 22677193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
    Li X; Zeng X
    Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis.
    Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B
    J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.
    Peng R; Zhang PF; Yang X; Wei CY; Huang XY; Cai JB; Lu JC; Gao C; Sun HX; Gao Q; Bai DS; Shi GM; Ke AW; Fan J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):113. PubMed ID: 30836988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
    Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
    Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6.
    Sun H; Tang H; Xie D; Jia Z; Ma Z; Wei D; Mishra L; Gao Y; Zheng S; Xie K; Peng Z
    Clin Cancer Res; 2016 Jan; 22(2):502-12. PubMed ID: 26338995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF2 inhibits TGF-β-mediated cancer cell motility in hepatocellular carcinoma.
    Li Y; Tu S; Zeng Y; Zhang C; Deng T; Luo W; Lian L; Chen L; Xiong X; Yan X
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):485-494. PubMed ID: 32318691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
    Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
    J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.
    Liu N; Jiao T; Huang Y; Liu W; Li Z; Ye X
    J Virol; 2015 Mar; 89(5):2739-49. PubMed ID: 25540364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
    Yan X; Wu J; Jiang Q; Cheng H; Han JJ; Chen YG
    J Mol Cell Biol; 2018 Feb; 10(1):48-59. PubMed ID: 29036306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1.
    Boon RA; Fledderus JO; Volger OL; van Wanrooij EJ; Pardali E; Weesie F; Kuiper J; Pannekoek H; ten Dijke P; Horrevoets AJ
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):532-9. PubMed ID: 17194892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor KLF4 modulates microRNA-106a that targets Smad7 in gastric cancer.
    Zhu M; Zhang N; He S
    Pathol Res Pract; 2019 Aug; 215(8):152467. PubMed ID: 31146975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma.
    Tian C; Yao S; Liu L; Ding Y; Ye Q; Dong X; Gao Y; Yang N; Li Q
    Int J Mol Med; 2017 Jan; 39(1):47-56. PubMed ID: 27909734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.
    Zhang S; Sun WY; Wu JJ; Gu YJ; Wei W
    Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.